Samsung has announced that it has received approval for the ECG feature in the Samsung Health Monitor app from the South Korean Ministry of Food and Drug Safety (MFDS). This means that the Galaxy Watch Active 2's ECG sensor can now be used to analyze the heart's rhythm for abnormalities such as atrial fibrillation (AFib).
AFib is one of the main causes of strokes and also increases the risk of complications such as blood clots and heart failure. However, it should be noted that the ECG monitoring function via the Samsung Health Monitor app is limited to the Galaxy Watch Active 2. However, it will likely also be available for its successors.
A month ago, MFDS 'Samsung Health Monitor app was also released for monitoring blood pressure and classified as "Software as a medical device (SaMD)". Thanks to the regulatory agency's nod, the Galaxy Watch Active 2 could be marketed as a government-approved device without a cuff to monitor blood pressure.